Atlas Trials

Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment

Clinical trial NCT01632436 · WITHDRAWN

Trial details

NCT number
NCT01632436
Sponsor
CTI BioPharma
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Cancer
Start date
2012-05-01
Primary completion
2017-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.